Exact Mass: 324.1177424
Exact Mass Matches: 324.1177424
Found 500 metabolites which its exact mass value is equals to given mass value 324.1177424,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Furaltadone
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
Prazepam
Prazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine that is used in the treatment of anxiety disorders. It is a schedule IV drug in the U.S. Prazepam is believed to stimulate GABA receptors in the ascending reticular activating system. Since GABA is inhibitory, receptor stimulation increases inhibition and blocks both cortical and limbic arousal following stimulation of the brain stem reticular formation. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Acetohexamide
C15H20N2O4S (324.11437200000006)
Acetohexamide is only found in individuals that have used or taken this drug. It is a sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide. [PubChem]Sulfonylureas such as acetohexamide bind to an ATP-dependent K+ channel on the cell membrane of pancreatic beta cells. This inhibits a tonic, hyperpolarizing outflux of potassium, which causes the electric potential over the membrane to become more positive. This depolarization opens voltage-gated Ca2+ channels. The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell membrane, and therefore increased secretion of (pro)insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
N-(6-Cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-N-methylethanesulfonamide
C15H20N2O4S (324.11437200000006)
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
Mycocyclosin
An organic heterotetracyclic compound obtained via intramolecular oxidative aromatic coupling of cyclo(L-tyrosyl-L-tyrosyl). D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines
Chromanol 293B
C15H20N2O4S (324.11437200000006)
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
Moracin L
Moracin L is found in fruits. Moracin L is produced by Morus alba (white mulberry) infected with Fusarium solani.
Moracin K
Production by Morus alba (white mulberry) infected with Fusarium solani. Moracin K is found in mulberry and fruits. Moracin K is found in fruits. Moracin K is produced by Morus alba (white mulberry) infected with Fusarium solani.
4-Hydroxywarfarin
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
DHAP(10:0)
C13H25O7P (324.13378300000005)
DHAP(10:0) is the decanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by decanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. [HMDB] DHAP(10:0) is the decanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by decanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts.
S-6-Hydroxywarfarin
S-6-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. S-6-Hydroxywarfarin is a metabolite of Warfarin. S-6-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
S-4'-Hydroxywarfarin
S-4-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. S-4-Hydroxywarfarin is a metabolite of Warfarin. S-4-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
R-4'-Hydroxywarfarin
R-4-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-4-Hydroxywarfarin is a metabolite of Warfarin. R-4-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
R-6-Hydroxywarfarin
R-6-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-6-Hydroxywarfarin is a metabolite of Warfarin. R-6-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
R-10-Hydroxywarfarin
R-10-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-10-Hydroxywarfarin is a metabolite of Warfarin. R-10-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
R-8-Hydroxywarfarin
R-8-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-8-Hydroxywarfarin is a metabolite of Warfarin. R-8-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
R-7-Hydroxywarfarin
R-7-Hydroxywarfarin is only found in individuals that have used or taken Warfarin. R-7-Hydroxywarfarin is a metabolite of Warfarin. R-7-hydroxywarfarin belongs to the family of Chromones. These are compounds containing a benzopyran-4-one moiety.
(R)-6-Hydroxywarfarin
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
3-Methylsulfonyl-4-piperidin-1-ylbenzoyl guanidine
C14H20N4O3S (324.12560500000006)
(4-Acetamidophenyl) (2S)-2-acetamido-4-methylsulfanylbutanoate
C15H20N2O4S (324.11437200000006)
Bicisate
3-((4-(5-(Hydroxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)benzonitrile
Difructose anhydride III
N-(N-Formyl-L-methionyl)-L-phenylalanine
C15H20N2O4S (324.11437200000006)
Furaltadone
2,2-Dimethyl-4-(4-methylsulfonylphenyl)-5-propoxyfuran-3-one
C16H20O5S (324.10313900000006)
NCI60_008951
Bavachin
Bavachin is a natural product found in Broussonetia papyrifera, Cullen corylifolium, and other organisms with data available. Bavachin, a flavonoid first isolated from seeds of P. corylifolia, acts as a phytoestrogen that activates the estrogen receptors ERα and ERβ with EC50s of 320 and 680 nM, respectively. Bavachin, a flavonoid first isolated from seeds of P. corylifolia, acts as a phytoestrogen that activates the estrogen receptors ERα and ERβ with EC50s of 320 and 680 nM, respectively.
Isobavachin
Isobavachin is a member of flavanones. Isobavachin is a natural product found in Brosimum acutifolium, Erythrina sigmoidea, and other organisms with data available. Isobavachin, an antioxidant isaolated from Psoralea corylifolia with a prenyl group at position 8 of ring A, promotes neuronal differentiation and the potential role of its protein prenylation[1][2]. Isobavachin, an antioxidant isaolated from Psoralea corylifolia with a prenyl group at position 8 of ring A, promotes neuronal differentiation and the potential role of its protein prenylation[1][2].
2,3,5,8,10-Pentahydroxy-3-methyl-6-methoxy-1,2,3,4,4a,9a-hexahydroanthracene-9(10H)-one
3,4-Methylenedioxy-2-methoxy-[2,3:4,3]-dihydrochalcone
10,10-Dimethyl-10a-[2-(2-thienyl)vinyl]-3,4,10,10a-tetrahydropyrimido[1,2-a]indol-2(1H)-one
1-(4-Methoxy-benzofuran-5-yl)-3-(1,3-benzodioxol-5-yl)propan-1-one
Di-Me ether-3-Acetyl-1,8-dihydroxy-2-methylphenanthraquinone
1-(3,4-Dihydroxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
1,2-Dihydro,1-hydroxy-(8alpha,9beta)-form-1,7,8,9-Tetrahydro-1,9-dihydroxy-4-methoxy-5-methyl-8-(1-methylethenyl)-3H-furo[3,4-f][1]benzopyran-3-one,
8-(3,4-dimethoxyphenyl)-2-methoxynaphtho-1,4-quinone
(2E,8E)-2,8-Decadiene-4,6-diyne-1,10-diol 1-O-??-D-glucopyranoside|(2E,8E)-deca-2,8-diene-4,6-diyne-1,10-diol 1-O-beta-D-glucopyranoside
1,8-dihydroxy-3-isoprenyloxy-6-methylanthraquinone
O-beta-D-Xylopyranoside-(R)-5,6,7,8-Tetrahydro-6-hydroxy-2-naphthalenecarboxylic acid
3-(4-Methoxyphenyl)-2-methyl-4-oxo-4H-chromen-7-yl acetate
2-(4-Acetoxyphenyl)-3-methyl-7-methoxybenzofuran-5-carbaldehyde
1-(4-hydroxybenzofuran-5-yl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
3(R)-deca-4,6,8-triyne-1,3-diol 1-O-beta-D-glucopyranoside|bidensyneoside B
2-(4-hydroxy-3-methoxyphenyl)-1,3-propanediol triacetate
5H-benzo[g]-1,3-benzodioxolo[5,6,4]quinoline-6,7,7a,8-tetrahydro-7-nitroso-10-methoxy-(7aR)|N-nitrosoxylopine
6-O-Desmethylterphenyllin
A para-terphenyl that is the 6-O-desmethyl deriavtive of terphenyllin. Isolated from Penicillium chermesinum, it exhibits inhibitory activity against alpha-glucosidase.
Methyl 2-benzyl-4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furoate
3-O-trans-p-methoxycinnamoyl-alpha-L-rhamnopyranose
2-(3,4-methylenedioxyphenyl)-5-[(E)-3-hydroxy-1-propenyl]-7-methoxybenzofuran|zanthocapensol
7-hydroxy-12-methoxy-2,2-dimethyl-2H-pyrano[3,2-b]xanthen-6-one|linixanthone B
5-Methoxy-6-methoxy-7-(2,3-dihydroxy-3-methylbutoxy)coumarin
5-(4-hydroxyphenethenyl)-4,7-dimethoxycoumarin|5-(4-hydroxyphenylethenyl)-4,7-dimethoxycoumarin
Bleitetraaethyl|Tetraaethyl-plumban|tetraethyl lead|tetraethyllead|tetraethyllead(IV)|tetraethylplumbane|tetraetyllead
3-(2-benzo[1,3]dioxol-5-yl-benzofuran-5-yl)-propionic acid methyl ester|methyl 3-[2-(3,4-methylenedioxyphenyl)-5-benzofuranyl]propionate
3-(4-hydroxy-3-methoxyphenyl)-1,2-propanediol triacetate
6-Methyl-7-(3,4-dimethoxyphenyl)-5H-indeno[5,6-d]-1,3-dioxole-5-one
6,9-dihydroxy-7,8-dimethoxy-2-propyl-2,3,3a,9b-tetrahydro-furo[3,2-c]isochromen-5-one|Hydroxymonocerin
Isobavachalcone
Isobavachalcone (Corylifolinin) is derived from Psoralea corylifolia Linn. and is a potent inhibitor of Akt signaling pathway, which induces apoptosis in human cancer cells (Inhibits OVCAR-8 cell growth with an IC50 value of 7.92 μM). Isobavachalcone also induces Reactive Oxyen Species (ROS) generation in OVCAR-8 cells and has exhibit cancer anti-promotive and anti-proliferative activity[1]. Isobavachalcone (Corylifolinin) is derived from Psoralea corylifolia Linn. and is a potent inhibitor of Akt signaling pathway, which induces apoptosis in human cancer cells (Inhibits OVCAR-8 cell growth with an IC50 value of 7.92 μM). Isobavachalcone also induces Reactive Oxyen Species (ROS) generation in OVCAR-8 cells and has exhibit cancer anti-promotive and anti-proliferative activity[1]. Isobavachalcone (Corylifolinin) is derived from Psoralea corylifolia Linn. and is a potent inhibitor of Akt signaling pathway, which induces apoptosis in human cancer cells (Inhibits OVCAR-8 cell growth with an IC50 value of 7.92 μM). Isobavachalcone also induces Reactive Oxyen Species (ROS) generation in OVCAR-8 cells and has exhibit cancer anti-promotive and anti-proliferative activity[1].
prazepam
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
acetohexamide
C15H20N2O4S (324.11437200000006)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4168; ORIGINAL_PRECURSOR_SCAN_NO 4165 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4170; ORIGINAL_PRECURSOR_SCAN_NO 4165 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4125; ORIGINAL_PRECURSOR_SCAN_NO 4121 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4143; ORIGINAL_PRECURSOR_SCAN_NO 4140 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4151; ORIGINAL_PRECURSOR_SCAN_NO 4150 ORIGINAL_PRECURSOR_SCAN_NO 4163; CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4165 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4165; ORIGINAL_PRECURSOR_SCAN_NO 4163 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8394; ORIGINAL_PRECURSOR_SCAN_NO 8389 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8413; ORIGINAL_PRECURSOR_SCAN_NO 8409 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8458; ORIGINAL_PRECURSOR_SCAN_NO 8454 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8489; ORIGINAL_PRECURSOR_SCAN_NO 8485 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8471; ORIGINAL_PRECURSOR_SCAN_NO 8468
7-HYDROXYWARFARIN
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
4-Hydroxywarfarin
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
Decanoyl dhap
C13H25O7P (324.13378300000005)
Bualta
C10H28Cl2N2OP2 (324.10538379999997)
Moracin L
2-Piperazinyl-4-amino-6,7-dimethoxyquinazoline hydrochloride
6-(3-Hydroxyprop-1-ynyl)-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
6-(Benzyloxy)-4-hydroxy-7-methoxy-2-naphthoic acid
Efloxate
C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)CYCLOPROPANESULFONAMIDE
C14H21BN2O4S (324.13150160000004)
Sumacetamol
C15H20N2O4S (324.11437200000006)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Methyl 2-O-acetyl-4,6-O-benzylidene-a-D-glucopyranoside
3-BIPHENYL-4-YL-1-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-4-carboxylate
methanesulfonic acid,2-(4-phenylmethoxyphenyl)ethanol
C16H20O5S (324.10313900000006)
L-Methionine,N-(N-formyl-L-phenylalanyl)- (9CI)
C15H20N2O4S (324.11437200000006)
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
(3AR,4R,5R,6AS)-4-((E)-3,3-DIFLUORO-4-PHENOXYBUT-1-EN-1-YL)-5-HYDROXYHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-2-ONE
ETHYL 1-BENZYL-4-HYDROXY-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE
Ethyl 4-hydroxy-7-methyl-2-oxo-1-phenyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate
10-HYDROXYWARFARIN
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
N-{4-[(1-Acetyl-4-piperidinyl)carbonyl]phenyl}methanesulfonamide
C15H20N2O4S (324.11437200000006)
4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID (3-METHOXY-PHENYL)-AMIDE
1,3-Bis((3-methyl-2,5-dioxopyrrol-1-yl)methyl)benzol
(2,4-Diphenyl-1-naphthyl)boronic acid
C22H17BO2 (324.13215319999995)
5,5-dimethyl-2-[[(2-phenoxyacetyl)amino]methyl]-1,3-thiazolidine-4-carboxylic acid
C15H20N2O4S (324.11437200000006)
Diethyl 2,2-(1,2-ethanediyldiimino)bis(3-sulfanylpropanoate)
1-Iodotetradecane
An organoiodine compound that is tetradecane substituted by an iodo group at position 1.
1-[4-Amino-3-chloro-5-(trifluoromethyl)phenyl]-2-(2-methylbutan-2-ylamino)ethanol
2-Amino-5-[(1-Methoxy-2-Methylindolizin-3-Yl)carbonyl]benzoic Acid
N-(3-fluorophenyl)-2-oxo-4,10-dihydro-3H-pyrimido[1,2-a]benzimidazole-4-carboxamide
5-Chloro-6-methyl-N-(2-phenylethyl)-2-pyridin-2-ylpyrimidin-4-amine
(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide
(2S) N-Acetyl-L-alanyl-alphal-phenylalanyl-chloroethylketone
N-[(2R)-4-diazonio-3-oxoniumylidene-1-phenylbutan-2-yl]-1-phenylmethoxymethanimidate
C18H18N3O3+ (324.13480979999997)
Stepharanine
A berberine alkaloid with formula C19H18NO4 that is isolated from several species of Stephania.
1,2,3,4-Tetrahydroquinoxalin-2,3-dione, 1-ribityl-6,7-dimethyl-
(R)-7-Hydroxywarfarin
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
2,9-Dihydroxy-3,10-Dimethoxy-5,6-Dihydroisoquino[3,2-A]isoquinolinium
(4aR,12bR)-4a,7,8-trihydroxy-3-methyl-5,12b-dihydro-4H-benzo[a]anthracene-1,6-dione
(1r,4r,5s,6s,7r,10r,11s,12s)-1,7-Bis(Hydroxymethyl)-2,8,13,14-Tetraoxatricyclo[8.2.1.1~4,7~]tetradecane-5,6,11,12-Tetrol
3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-D-galactose
alpha-D-fructofuranose beta-D-fructofuranose 1,2:1,2-dianhydride
(1E,6E)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
N,N-((1Z,3Z)-1,4-bis(4-hydroxyphenyl)buta-1,3-diene-2,3-diyl)diformamide
A natural product found particularly in Aspergillus fumigatus and Penicillium notatum.
N4-(3-chlorophenyl)-6-methyl-N2-(phenylmethyl)pyrimidine-2,4-diamine
2-{2,5-dimethyl-3-[(E)-(4H-1,2,4-triazol-4-ylimino)methyl]-1H-pyrrol-1-yl}-4,5-dimethylthiophene-3-carbonitrile
N-(2-fluorophenyl)-2-[3-(1-oxopropyl)-1-indolyl]acetamide
N-[4-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-5,7-dimethyl-3-pyrazolo[1,5-a]pyrimidinecarboxamide
C17H16N4O3 (324.12223459999996)
N-[3-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide
1-Phenylmethoxy-4-prop-2-enoxyquinoxaline-2,3-dione
1,3-Benzothiazol-2-yl-[4-(2-pyridinyl)-1-piperazinyl]methanone
N-[4-[2-[(6-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide
1-Decanoyl-sn-glycero-3-phosphate(2-)
C13H25O7P-2 (324.13378300000005)
N-[2-(4-methylphenoxy)-1-oxoethyl]-2-benzofurancarbohydrazide
2-[(4-methyl-2-oxo-1-benzopyran-7-yl)oxy]-N-(2-pyridinylmethyl)acetamide
4-Chloro-3-[[2-(4-methyl-1-piperidinyl)-1-oxoethyl]amino]benzoic acid methyl ester
6-Amino-4-(1-cyclohex-2-enyl)-3-thiophen-2-yl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
methyl N-(tert-butoxycarbonyl)-4-nitrophenylalaninate
methyl 8-[(2E)-2-[(2-chlorophenyl)methylidene]hydrazinyl]-8-oxooctanoate
alpha-N-(9-beta-D-ribofuranosylpurin-6-yl)glycinamide
alpha-D-Fructofuranose beta-D-fructopyranose 1,2:2,1-dianhydride
3,4,5-trihydroxy-6-[(E)-2-methyl-3-phenylprop-2-enoxy]oxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(E)-4-phenylbut-3-en-2-yl]oxyoxane-2-carboxylic acid
4-Hydroxy-3-[1-(2-hydroxyphenyl)-3-oxobutyl]chromen-2-one
S-(2,5-Diacetoxy-3,4,6-trimethyl-phenylmethyl)thioacetate
C16H20O5S (324.10313900000006)
Levofuraltadona
C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
bis-beta-D-fructofuranose 1,2:2,3-dianhydride
A sugar dianhydride obtained by the condensation of two units of beta-D-fructofuranose.
HMR1556
C15H20N2O4S (324.11437200000006)
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
[3-(decanoyloxy)-2-oxopropoxy]phosphonic acid
C13H25O7P (324.13378300000005)
1-Decanoyl-sn-glycero-3-phosphate(2-)
C13H25O7P (324.13378300000005)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-capryl-sn-glycero-3-phosphate.
SP-141
SP-141 is a specific inhibitor of MDM2. SP-141 promotes MDM2 auto-ubiquitination and degradation. SP-141 might be used for the research of pancreatic cancer and breast cancer cells[1].
1,4,6,7,10-pentahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
2-[(10-hydroxydeca-2,8-dien-4,6-diyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4-[(4s,5s)-4-hydroxy-2',4'-dioxaspiro[cyclopentane-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),2,5',7',9',11'-hexaen-5-yl]but-2-enoic acid
(12r)-7,8-dimethoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
(4e,6e)-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-4,6-dien-3-one
(12s)-7,8-dimethoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
(2r,4r,6r)-10-hydroxy-4-[(1r)-1-hydroxypropyl]-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
4-hydroxy-3-[(1s)-1-(3-hydroxyphenyl)-3-oxobutyl]chromen-2-one
7-(2,3-dihydroxy-3-methylbutoxy)-6,8-dimethoxychromen-2-one
5-{6,7-dimethyl-2h,5h,6h,7h,8h-naphtho[2,3-d][1,3]dioxol-5-yl}-2h-1,3-benzodioxole
(2r,4s,6r)-10-hydroxy-4-(3-hydroxypropyl)-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
7-hydroxy-3-isopropyl-5,5,9-trimethylanthracene-1,2,6-trione
6-[9-(furan-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one
7-hydroxy-12-methoxy-2,2-dimethyl-1,11-dioxatetracen-6-one
4,5,6-trihydroxy-2-methyloxan-3-yl 3-(4-methoxyphenyl)prop-2-enoate
2-[3-hydroxy-5-methoxy-4-(3-methylbut-2-en-1-yl)phenyl]-1-benzofuran-6-ol
4-hydroxy-3-[1-(3-hydroxyphenyl)-3-oxobutyl]chromen-2-one
n-[2-(2',6-dihydroxy-5'-{2-[(hydroxymethylidene)amino]ethenyl}-[1,1'-biphenyl]-3-yl)ethenyl]carboximidic acid
(2s)-7-hydroxy-8-[(1z)-3-hydroxy-3-methylbut-1-en-1-yl]-2-phenyl-2,3-dihydro-1-benzopyran-4-one
5-[(1e)-prop-1-en-1-yl]-2-(2,4,6-trimethoxyphenyl)-1-benzofuran
2,3,5-trihydroxy-6-methyloxan-4-yl 3-(4-methoxyphenyl)prop-2-enoate
(2r,4s,6r)-10,13-dihydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-8-one
1,5-dihydroxy-2-isoprenyl-3-methoxyxanthone
{"Ingredient_id": "HBIN001658","Ingredient_name": "1,5-dihydroxy-2-isoprenyl-3-methoxyxanthone","Alias": "NA","Ingredient_formula": "C19H16O5","Ingredient_Smile": "CC(=C)C=CC1=C(C=C2C(=C1O)C(=O)C3=C(O2)C(=CC=C3)O)OC","Ingredient_weight": "324.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5924","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129716102","DrugBank_id": "NA"}
1,7-dihydroxy-2-isoprenyl-3-methoxyxanthone
{"Ingredient_id": "HBIN002012","Ingredient_name": "1,7-dihydroxy-2-isoprenyl-3-methoxyxanthone","Alias": "NA","Ingredient_formula": "C19H16O5","Ingredient_Smile": "CC(=C)C=CC1=C(C=C2C(=C1O)C(=O)C3=C(O2)C=CC(=C3)O)OC","Ingredient_weight": "324.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5925","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129716110","DrugBank_id": "NA"}
(2 e,8 e)-2,8-decadiene-4,6-diyne-1,10-diol 1-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN005575","Ingredient_name": "(2 e,8 e)-2,8-decadiene-4,6-diyne-1,10-diol 1-o-\u03b2-d-glucopyranoside","Alias": "(2e,8 e)-2,8-decadiene-4,6-diyne-1,10-diol 1-o-\u03b2-d-glucopyranoside","Ingredient_formula": "C16H20O7","Ingredient_Smile": "C(C=CC#CC#CC=CCOC1C(C(C(C(O1)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14913","TCMID_id": "4817","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ajuforrestine a
{"Ingredient_id": "HBIN014959","Ingredient_name": "ajuforrestine a","Alias": "NA","Ingredient_formula": "C20H20O4","Ingredient_Smile": "CC1=C(C2=CC(=O)C3=C(C4=C(C(=C3C2(CC1)C)O)OC=C4C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "786","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anticancer diarylheptanoid pmv70p691-010
{"Ingredient_id": "HBIN016318","Ingredient_name": "anticancer diarylheptanoid pmv70p691-010","Alias": "NA","Ingredient_formula": "C20H20O4","Ingredient_Smile": "COC1=C(C=C2CCC3C(C2=C1)C=CC(O3)C4=CC=C(C=C4)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1393","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
avicennin
{"Ingredient_id": "HBIN017404","Ingredient_name": "avicennin","Alias": "NA","Ingredient_formula": "C20H20O4","Ingredient_Smile": "CC(=C)C=CC1=C(C2=C(C3=C1OC(=O)C=C3)OC(C=C2)(C)C)OC","Ingredient_weight": "324.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2035","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5321265","DrugBank_id": "NA"}
bavachin
{"Ingredient_id": "HBIN017632","Ingredient_name": "bavachin","Alias": "NA","Ingredient_formula": "C20H20O4","Ingredient_Smile": "CC(=CCC1=CC2=C(C=C1O)OC(CC2=O)C3=CC=C(C=C3)O)C","Ingredient_weight": "324.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2172","TCMSP_id": "NA","TCM_ID_id": "6419","PubChem_id": "26436537","DrugBank_id": "NA"}
bidensyneoside b
{"Ingredient_id": "HBIN018480","Ingredient_name": "bidensyneoside b","Alias": "NA","Ingredient_formula": "C16H20O7","Ingredient_Smile": "CC#CC#CC#CC(CCOC1C(C(C(C(O1)CO)O)O)O)O","Ingredient_weight": "324.32 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2361","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10892676","DrugBank_id": "NA"}
6-methoxy-4-phenyl-[1,1'-biphenyl]-2,2',5,5'-tetrol
(10e,12r)-4-methoxy-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,8,10,15,18-octaene-5,12-diol
methyl (2r)-2-benzyl-4-hydroxy-5-oxo-3-phenylfuran-2-carboxylate
(2r)-2-hydroxy-2-[(2r,3s,4r)-4-hydroxy-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl]acetaldehyde
(12s,13s)-3,13-dihydroxy-12-(2-hydroxypropan-2-yl)-7-methoxy-8-methyl-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-trien-5-one
(2s)-5,7-dihydroxy-6-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(11r)-11-(2,4-dimethoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,5,7-tetraen-10-one
(2s,3as,6as)-2,3,3a,6a-tetrahydro-2',4'-dioxaspiro[cyclopenta[b]furan-4,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-2-ylacetic acid
tert-butyl 2-(9-hydroxy-10-oxophenanthren-9-yl)acetate
4-(5-formyl-7-methoxy-3-methyl-1-benzofuran-2-yl)phenyl acetate
10-hydroxy-4-(2-hydroxypropyl)-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
(2s)-5,7-dihydroxy-8-[(1e)-3-methylbut-1-en-1-yl]-2-phenyl-2,3-dihydro-1-benzopyran-4-one
{9-methoxy-5-methylnaphtho[2,3-b]furan-4-yl}methyl (2z)-2-methylbut-2-enoate
8-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)benzo[g]chromene-5,10-dione
2-hydroxy-n-[(2s,3r)-3-hydroxy-1-oxo-1-propoxybutan-2-yl]-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
10-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene-5,14-diol
(3s,12r,13r)-3,13-dihydroxy-12-(2-hydroxypropan-2-yl)-7-methoxy-8-methyl-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-trien-5-one
9-hydroxy-2,5,5-trimethyl-3,4,4a,12b-tetrahydro-6-oxatetraphene-7,12-dione
2-[4-hydroxy-2-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-1-benzofuran-6-ol
(2s)-7-hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-methoxy-4-{7-methoxy-3-methyl-5-[(1e)-prop-1-en-1-yl]-1-benzofuran-2-yl}phenol
3,6,9-trihydroxy-5,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
(3r)-3-[(2s)-6-hydroxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-3,4-dihydro-2h-1-benzopyran-7-ol
2-(acetyloxy)ethyl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
n-[(1z,3z)-3-[(hydroxymethylidene)amino]-1,4-bis(4-hydroxyphenyl)buta-1,3-dien-2-yl]carboximidic acid
5-(prop-1-en-1-yl)-2-(2,4,6-trimethoxyphenyl)-1-benzofuran
n-[11-imino-6-(3-methoxyprop-2-enoyl)-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,5,8(12),9-pentaen-9-yl]propanimidic acid
C17H16N4O3 (324.12223459999996)
13-hydroxy-4-methoxy-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,8,15,18-heptaen-12-one
10-hydroxy-4-(3-hydroxypropyl)-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
(2r,3r,4s,5s,6r)-2-{[(2e,8e)-10-hydroxydeca-2,8-dien-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-[6-methoxy-7-(3-methylbut-2-en-1-yl)-1-benzofuran-2-yl]benzene-1,3-diol
(2r,4s,6r)-10-hydroxy-4-[(2s)-2-hydroxypropyl]-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
8-hydroxy-3-methyl-1-(4-methyl-5-oxooxolan-2-yl)xanthen-9-one
(1s,13s)-17,18-dimethoxy-7,11,20-trioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-2(10),3,5,8,14,16,18-heptaene
1-(2,4-dihydroxyphenyl)-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
5-[(2s)-2,3-dihydroxy-3-methylbutoxy]-7,8-dimethoxychromen-2-one
4-{1-hydroxy-3-[2-(hydroxymethyl)-3-methoxyphenyl]prop-2-en-1-yl}-5-(1-hydroxyethyl)-1,3-dioxolan-2-one
(4as,12bs)-9-hydroxy-2,5,5-trimethyl-3,4,4a,12b-tetrahydro-6-oxatetraphene-7,12-dione
6-hydroxy-8-[2-(4-hydroxyphenyl)-2-oxoethyl]-3-methyl-2h-1-benzoxepin-5-one
1,7-bis(hydroxymethyl)-2,8,13,14-tetraoxatricyclo[8.2.1.1⁴,⁷]tetradecane-5,6,11,12-tetrol
2,5,10-trimethoxy-3,8-dimethylcyclohepta[a]naphthalen-9-one
(2r,3r,4s,5s,6r)-2-{[(3r)-3-hydroxydeca-4,6,8-triyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,14-diol
5-[(3s)-7-methoxy-3-methyl-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran-2-yl]-2h-1,3-benzodioxole
6-hydroxy-3-methyl-8-(2-phenylethyl)-2,5-dihydro-1-benzoxepine-9-carboxylic acid
1,5,6,7,10-pentahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
10,13-dihydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-8-one
2-(3,4-dimethoxyphenyl)-3-methyl-7-(prop-2-en-1-yl)-1-benzofuran-5-ol
8,9-dihydroxy-7-methoxy-11,11-dimethyl-4bh,10h,10ah-benzo[b]fluoren-5-one
(1r,10r)-6-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,14-diol
8-hydroxy-1-(hydroxymethyl)-3-methyl-5-(3-methylbut-2-en-1-yl)xanthen-9-one
5-hydroxy-2,8,8-trimethyl-6-[(1e)-3-methylbuta-1,3-dien-1-yl]pyrano[2,3-f]chromen-4-one
(11bs)-7,11-dihydroxy-4,4,9,11b-tetramethyl-1h-phenanthro[3,2-b]furan-6-one
2,6-dimethoxy-4-(prop-2-en-1-yl)phenyl (2e)-3-phenylprop-2-enoate
4a,5',6-tris(hydroxymethyl)-tetrahydrospiro[furo[2,3-b][1,4]dioxine-2,2'-oxolane]-3',4',7-triol
7,8-dimethoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
(3r,4as,5s,10ar)-5,6,9-trihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
(2s)-2-hydroxy-2-[(2s,3r,4s)-4-hydroxy-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl]acetaldehyde
10-hydroxy-4-(1-hydroxypropyl)-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
{9-methoxy-5-methylnaphtho[2,3-b]furan-4-yl}methyl 2-methylbut-2-enoate
(2e)-1-(5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl)-3-phenylprop-2-en-1-one
4a,7,8-trihydroxy-3-methyl-5,12b-dihydro-4h-tetraphene-1,6-dione
3,11-dihydroxy-4,10-dimethoxy-7,8-dihydro-6λ⁵-azatetraphen-6-ylium
(2r,3s,4s,5r,8s,10s,11r,12r)-2,10-bis(hydroxymethyl)-1,6,9,13-tetraoxadispiro[4.2.4⁸.2⁵]tetradecane-3,4,11,12-tetrol
1-(5,7-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-8-yl)-3-phenylprop-2-en-1-one
1-(4,5-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)-3-phenylprop-2-en-1-one
5-hydroxy-2,8,8-trimethyl-6-(3-methylbuta-1,3-dien-1-yl)pyrano[2,3-f]chromen-4-one
3-phenyl-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
16,17-dihydroxy-1-methyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2(10),3,5(9),12(19),14-pentaene-6,11-dione
6-[(3,4,5-trihydroxyoxan-2-yl)oxy]-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid
(4ar,12br)-4a,7,8-trihydroxy-3-methyl-5,12b-dihydro-4h-tetraphene-1,6-dione
5-(2,3-dihydroxy-3-methylbutoxy)-7,8-dimethoxychromen-2-one
(6s,7r)-1,4,6,7,10-pentahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
2-[4-hydroxy-2-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-1-benzofuran-6-ol
7-(3-chloroprop-1-en-2-yl)-12-hydroxy-4-methyl-3,14-dioxatetracyclo[10.2.1.0²,¹⁰.0⁴,⁸]pentadec-2(10)-en-11-one
C17H21ClO4 (324.11282960000005)
1-(5-hydroxy-2,2-dimethylchromen-6-yl)-3-(4-hydroxyphenyl)propan-1-one
4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one
5-[(1e)-2-(4-hydroxyphenyl)ethenyl]-4,7-dimethoxychromen-2-one
(2s,3r,4r,5r,6s)-2,4,5-trihydroxy-6-methyloxan-3-yl (2z)-3-(4-methoxyphenyl)prop-2-enoate
(4z,6e)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-phenylhepta-4,6-dien-3-one
8-[(3s)-7-hydroxy-3,4-dihydro-2h-1-benzopyran-3-yl]-2,2-dimethylchromen-5-ol
methyl 3-[2-(2h-1,3-benzodioxol-5-yl)-1-benzofuran-5-yl]propanoate
6-[(2e,4e,6e,8e)-9-(furan-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one
5-[(2s,3s)-7-methoxy-3-methyl-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran-2-yl]-2h-1,3-benzodioxole
(1s,10s)-4-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,14-diol
(1s,12s,13s,16r,18r)-18-(hydroxymethyl)-16,18-dimethyl-17-oxapentacyclo[11.4.1.0¹,¹⁰.0³,⁸.0¹²,¹⁶]octadeca-3,5,7,10-tetraene-2,9-dione
(4bs,10ar)-4b,9-dihydroxy-7-methoxy-11,11-dimethyl-10h,10ah-benzo[b]fluoren-5-one
5-(prop-1-en-1-yl)-2-(2,4,5-trimethoxyphenyl)-1-benzofuran
5-hydroxy-2,2-dimethyl-7-(2-phenylethyl)chromene-6-carboxylic acid
7-(2,3-dihydroxy-3-methylbutoxy)-5,6-dimethoxychromen-2-one
7-[(2s)-2,3-dihydroxy-3-methylbutoxy]-5,6-dimethoxychromen-2-one
(1r,3's,5's)-3',4-dihydroxy-5,6-dimethoxy-5'-propylspiro[2-benzofuran-1,2'-oxolan]-3-one
[3-(acetyloxy)-1,2,6-trihydroxycyclohexyl]methyl benzoate
13-hydroxy-6-isopropyl-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3(8),6,10,14-pentaene-4,5,9-trione
(1r,16r,17s)-16,17-dihydroxy-1-methyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2(10),3,5(9),12(19),14-pentaene-6,11-dione
(1r,2r,3r,4as,9ar,10r)-1,2,3,5,10-pentahydroxy-7-methoxy-2-methyl-1,3,4,4a,9a,10-hexahydroanthracen-9-one
5-[(2r,3r)-7-methoxy-3-methyl-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran-2-yl]-2h-1,3-benzodioxole
4-[(3r)-8,8-dimethyl-2h,3h,4h-pyrano[3,2-g]chromen-3-yl]benzene-1,3-diol
(2r)-5-hydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
methyl 1,6-dihydroxy-2-methyl-5-oxo-10-(prop-1-en-2-yl)-4,8-dioxatetracyclo[5.4.1.0²,⁶.0³,⁹]dodecane-11-carboxylate
5-{7,8-dimethyl-2h,6h,7h,8h,9h-naphtho[1,2-d][1,3]dioxol-9-yl}-2h-1,3-benzodioxole
1-{2,6-dihydroxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-3-phenylprop-2-en-1-one
(1r,5r,6r,7s,11s,12s)-1,7-bis(hydroxymethyl)-2,8,13,14-tetraoxatricyclo[8.2.1.1⁴,⁷]tetradecane-5,6,11,12-tetrol
5-[(2s,3s)-7-methoxy-3-methyl-5-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-2-yl]-2h-1,3-benzodioxole
(12s,13r)-3,13-dihydroxy-12-(2-hydroxypropan-2-yl)-7-methoxy-8-methyl-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-trien-5-one
(3s,4ar,10bs)-3-(4-hydroxyphenyl)-9-methoxy-3h,4ah,5h,6h,10bh-benzo[f]chromen-8-ol
2-methoxy-4-[7-methoxy-3-methyl-5-(prop-2-en-1-yl)-1-benzofuran-2-yl]phenol
7,11-dihydroxy-4,4,9,11b-tetramethyl-1h-phenanthro[3,2-b]furan-6-one
(8e,13s)-13-hydroxy-4-methoxy-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,8,15,18-heptaen-12-one
3-[2-(2h-1,3-benzodioxol-5-yl)-3-methyl-1-benzofuran-5-yl]butan-2-ol
(2r)-1-(acetyloxy)-3-[4-(acetyloxy)-3-methoxyphenyl]propan-2-yl acetate
(2e)-3-(3,4-dimethoxyphenyl)-1-(4-hydroxy-1-benzofuran-5-yl)prop-2-en-1-one
2-(acetyloxy)ethyl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate
2,5,11-trimethoxy-3,8-dimethylcyclohepta[a]naphthalen-9-one
2,3,3a,6a-tetrahydro-2',4'-dioxaspiro[cyclopenta[b]furan-4,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-2-ylacetic acid
7-(3,4-dimethoxyphenyl)-6-methyl-2h-indeno[5,6-d][1,3]dioxol-5-one
(2r,4r,6r)-10-hydroxy-4-[(1s)-1-hydroxypropyl]-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
(2s)-7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
5-methoxy-2,2-dimethyl-4h-1,3-dioxatetracene-6,11-dione
1,4-dihydroxy-4b,7,8-trimethyl-2-(prop-2-en-1-yl)-5h-phenanthrene-3,6-dione
(2e)-1-[(4s)-4,5-dihydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]-3-phenylprop-2-en-1-one
7-hydroxy-8-(3-hydroxy-3-methylbut-1-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
18-(hydroxymethyl)-16,18-dimethyl-17-oxapentacyclo[11.4.1.0¹,¹⁰.0³,⁸.0¹²,¹⁶]octadeca-3,5,7,10-tetraene-2,9-dione
3-(acetyloxy)-5-[3-(6-oxo-2,3-dihydropyran-2-yl)oxiran-2-yl]pent-4-en-2-yl acetate
2-methoxy-4-[7-methoxy-3-methyl-5-(prop-1-en-1-yl)-1-benzofuran-2-yl]phenol
8-hydroxy-3-methyl-1-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]xanthen-9-one
3-(3,4-dimethoxyphenyl)-1-(4-hydroxy-1-benzofuran-5-yl)prop-2-en-1-one
3-(acetyloxy)-2-[4-(acetyloxy)-3-methoxyphenyl]propyl acetate
(2s,3's,4's,4ar,5'r,6r,7r,7as)-4a,5',6-tris(hydroxymethyl)-tetrahydrospiro[furo[2,3-b][1,4]dioxine-2,2'-oxolane]-3',4',7-triol
methyl 2-benzyl-4-hydroxy-5-oxo-3-phenylfuran-2-carboxylate
(13r)-13-hydroxy-6-isopropyl-12,12-dimethyltricyclo[9.4.0.0³,⁸]pentadeca-1,3(8),6,10,14-pentaene-4,5,9-trione
methyl (1r,2r,3s,6s,7s,9r,10r,11s)-1,6-dihydroxy-2-methyl-5-oxo-10-(prop-1-en-2-yl)-4,8-dioxatetracyclo[5.4.1.0²,⁶.0³,⁹]dodecane-11-carboxylate
(5r,6r,7r,8as,10r,10as)-1,5,6,7,10-pentahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
(2s)-7-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
methyl (2s)-2-benzyl-4-hydroxy-5-oxo-3-phenylfuran-2-carboxylate
(3r)-3,8,12-trihydroxy-3-methyl-4,12-dihydro-2h-tetraphene-1,7-dione
1-(acetyloxy)-3-[4-(acetyloxy)-3-methoxyphenyl]propan-2-yl acetate
16,18-dihydroxy-1-methyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2,4,9,12(19),14-pentaene-6,11-dione
(2r,5r)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(1-hydroxypropan-2-yl)oxolane-2-carboxylic acid
3,7,8-trihydroxy-3-methyl-4,5-dihydro-2h-tetraphene-1,6-dione
(5r,6r,7r,8as,10r,10ar)-1,5,6,7,10-pentahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
(2s,3r,4r,5s,6s)-2,3,5-trihydroxy-6-methyloxan-4-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate
(3s,12s,13r)-3,13-dihydroxy-12-(2-hydroxypropan-2-yl)-7-methoxy-8-methyl-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-trien-5-one
(4s)-4-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one
1,2,3,5,10-pentahydroxy-7-methoxy-2-methyl-1,3,4,4a,9a,10-hexahydroanthracen-9-one
(11s)-11-(2,4-dimethoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,5,7-tetraen-10-one
6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-7-methoxynaphthalene-2-carbaldehyde
2-butanoyl-1,8-dihydroxy-3-methylanthracene-9,10-dione
(4s)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-naphthalen-1-one
4-{3-[4-(acetyloxy)phenyl]-3-oxoprop-1-en-1-yl}phenyl acetate
[(1r,2s,3r,6s)-3-(acetyloxy)-1,2,6-trihydroxycyclohexyl]methyl benzoate
3-(2h-1,3-benzodioxol-5-yl)-1-(4-methoxy-1-benzofuran-5-yl)propan-1-one
(2s,3r,4s,5r,6r)-4,5,6-trihydroxy-2-methyloxan-3-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate
3,13-dihydroxy-12-(2-hydroxypropan-2-yl)-7-methoxy-8-methyl-4,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),2(6),7-trien-5-one
2,10-bis(hydroxymethyl)-1,6,9,13-tetraoxadispiro[4.2.4⁸.2⁵]tetradecane-3,4,11,12-tetrol
2-hydroxy-2-(4-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-yl)acetaldehyde
(1r,16s,18s)-16,18-dihydroxy-1-methyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-2,4,9,12(19),14-pentaene-6,11-dione
(1s,2s,3r)-1-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-2-hydroxy-3-(hydroxymethyl)cyclohexane-1-carboxylic acid
5-[2-(4-hydroxyphenyl)ethenyl]-4,7-dimethoxychromen-2-one
(2s,3r,4r,5r,6s)-2,4,5-trihydroxy-6-methyloxan-3-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate
4-[(1e)-3-[4-(acetyloxy)phenyl]-3-oxoprop-1-en-1-yl]phenyl acetate
2,4,5-trihydroxy-6-methyloxan-3-yl 3-(4-methoxyphenyl)prop-2-enoate
6-hydroxy-12-methoxy-2,2-dimethyl-1,10-dioxatetraphen-5-one
n-[(1e)-2-{2',6-dihydroxy-5'-[(1e)-2-[(hydroxymethylidene)amino]ethenyl]-[1,1'-biphenyl]-3-yl}ethenyl]carboximidic acid
(3r,4as,5r,10as)-3,6,9-trihydroxy-5,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
(1r,4r,5s,6s,7r,10r,11s,12s)-1,7-bis(hydroxymethyl)-2,8,13,14-tetraoxatricyclo[8.2.1.1⁴,⁷]tetradecane-5,6,11,12-tetrol
1,6-dihydroxy-5-methoxy-7-(3-methylbuta-1,3-dien-1-yl)xanthen-9-one
methyl 2-benzyl-4-oxo-5-(phenylmethylidene)-1,3-dioxolane-2-carboxylate
(4r,5s)-4-[(1r,2e)-1-hydroxy-3-[2-(hydroxymethyl)-3-methoxyphenyl]prop-2-en-1-yl]-5-[(1s)-1-hydroxyethyl]-1,3-dioxolan-2-one
(2s,4e)-4-{2-[(1-carboxy-2-methylbutyl)imino]ethylidene}-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid
(6r)-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid
methyl (2r)-2-benzyl-4-oxo-5-(phenylmethylidene)-1,3-dioxolane-2-carboxylate
2-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(1-hydroxypropan-2-yl)oxolane-2-carboxylic acid
(4r,5r,8r,9e)-5,8-dihydroxy-9-(2-hydroxyethylidene)-4-propyl-4h,5h,7h,8h,10h-cyclonona[c]furan-1,3,6-trione
(2r,4s,6r)-10-hydroxy-4-[(2r)-2-hydroxypropyl]-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
3',4-dihydroxy-5,6-dimethoxy-5'-propylspiro[2-benzofuran-1,2'-oxolan]-3-one
(1e,3r,4s)-4-(acetyloxy)-1-[(2s,3r)-3-[(2r)-6-oxo-2,3-dihydropyran-2-yl]oxiran-2-yl]pent-1-en-3-yl acetate
(2s,4e)-4-[(2e)-2-[(1-carboxy-3-methylbutyl)imino]ethylidene]-2,3-dihydro-1h-pyridine-2,6-dicarboxylic acid
(2s,4r,6s)-10-hydroxy-4-[(2r)-2-hydroxypropyl]-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
2-[(3-hydroxydeca-4,6,8-triyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
5,6,9-trihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
methyl 1-[(2,4-dimethoxyphenyl)amino]-2-methoxy-5-oxopyrrolidine-2-carboxylate
(1s,3's,5's)-3',4-dihydroxy-5,6-dimethoxy-5'-propylspiro[2-benzofuran-1,2'-oxolan]-3-one
(3r,4as,5r,10ar)-5,6,9-trihydroxy-3,7-dimethoxy-3-methyl-1h,4h,4ah,5h,10ah-naphtho[2,3-c]pyran-10-one
6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-5-methoxynaphthalene-2-carbaldehyde
4-{4-hydroxy-2',4'-dioxaspiro[cyclopentane-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),2,5',7',9',11'-hexaen-5-yl}but-2-enoic acid
7-[(2s)-2,3-dihydroxy-3-methylbutoxy]-6,8-dimethoxychromen-2-one
(2s,5s)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-5-(1-hydroxypropan-2-yl)oxolane-2-carboxylic acid
1,6-dihydroxy-5-methoxy-7-[(1e)-3-methylbuta-1,3-dien-1-yl]xanthen-9-one
(1r,3r,4s,5r)-1,3,4-trihydroxy-5-{[3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}cyclohexane-1-carboxylic acid
8-(3,4-dimethoxyphenyl)-2-methoxynaphthalene-1,4-dione
(2r,3's,4's,4ar,5'r,6r,7r,7as)-4a,5',6-tris(hydroxymethyl)-tetrahydrospiro[furo[2,3-b][1,4]dioxine-2,2'-oxolane]-3',4',7-triol
(1s,4r,7r,8s,12r)-7-(3-chloroprop-1-en-2-yl)-12-hydroxy-4-methyl-3,14-dioxatetracyclo[10.2.1.0²,¹⁰.0⁴,⁸]pentadec-2(10)-en-11-one
C17H21ClO4 (324.11282960000005)